Picture of Rani Therapeutics Holdings logo

RANI — Rani Therapeutics Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Rani Therapeutics Holdings Inc reports results for the quarter ended in December - Earnings Summary

* Rani Therapeutics Holdings Inc  RANI.OQ  reported a
quarterly
adjusted loss of 27 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -35 cents.  The mean expectation of
seven analysts for the quarter was for a loss of 31 cents per
share. Wall Street expected results to range from -37 cents
to -24 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Rani Therapeutics Holdings Inc's reported EPS for the
quarter
was a loss of 27 cents​.
    * The company reported a quarterly loss of $7.1 million.
    * Rani Therapeutics Holdings Inc shares had risen by 6.9%
this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Rani Therapeutics
Holdings Inc is $10.00 
This summary was machine generated from LSEG data March 20 at
09:01 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.31          -0.27          Beat
 Sep. 30 2023      -0.37          -0.36          Beat
 Jun. 30 2023      -0.40          -0.37          Beat
 Mar. 31 2023      -0.41          -0.33          Beat

Recent news on Rani Therapeutics Holdings

See all news